Fort Myers, Florida, May 02, 2022 (GLOBE NEWSWIRE) — Florida Cancer Specialists & Research Institute medical oncologist Ernesto Bustinza-Linares, MD is serving as a Principal Investigator in a global clinical trial collaboration that will analyze the responsiveness of certain cancer patients to immunotherapy treatment. The trial, known as PROPHETIC, involves patients with Stage IV non-small cell lung cancer, small cell lung cancer or malignant melanoma, and seeks to determine who will or will not respond to various forms of immunotherapies.

Read more here.